Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Lotte Biologics to Open Bio Plant in Incheon | Contract Pharma

What are you searching for?

Sign in
Breaking News

Lotte Biologics to Open Bio Plant in Incheon

By 2030 three bio plants aims to produce a total antibody medicine production capacity of 360,000 liters.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

LOTTE Biologics, a contract development and manufacturing organization (CDMO), plans to open a bio plant in Incheon Songdo. Last October, the company signed a land purchase agreement with the Incheon Free Economic Zone Authority to build a plant in Songdo International City, Incheon. By 2030, the company plans to construct three bio plants where it expects to produce a total antibody medicine production capacity of 360,000 liters.

Construction on the plant, which is set to commence this year, will be a mammalian cell culture facility with a production capacity of 120,000 liters. As part of the ‘Titer Flex Quad Bioreactor System, the facility will feature 15,000-liter stainless steel bioreactors for current titer needs as well as 3,000-liter stainless steel bioreactors for high-titer pharmaceutical manufacturing, fulfilling potential client needs for pharmaceutical production while also improving cost-efficiency.

CEO Richard Lee said, “LOTTE Biologics bio plant in Songdo will not just be a production facility but embody innovative solutions for a better human life. We are committed to evolving as a global CDMO, ensuring on-time-in-full delivery of necessary pharmaceuticals to patients.”  

  

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics